
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for CLCGY and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for CLCGY and 80,000+ other tickers.
See exactly how CLCGY's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for CLCGY and 80,000+ other tickers.
Clicks Group Ltd. is a retail-led healthcare group that operates as a retailer and wholesaler of health, pharmacy, and beauty products, primarily in Southern Africa. The company's main retail brand is Clicks, a health and beauty retailer, and it also owns UPD, a leading full-range pharmaceutical wholesaler.

BBIB, BGSI and CLCGY have been added to the Zacks Rank #5 (Strong Sell) List on June 30, 2026.

Clicks Group Limited (CLCGY) Q2 2026 Earnings Call Transcript